Our Clinical Trials
Select your nearest location above for the full list of local trials, or scroll though the latest studies below.
This Phase 3, randomised, placebo-controlled, observer-blind clinical trial is designed to evaluate the safety, efficacy and immunogenicity of an investigational vaccine (mRNA-1647) for CMV in healthy volunteers.
A Phase 3 Clinical Study to Evaluate the Safety and Immunogenicity of Experimental Pneumococcal Vaccine.
This Phase 3, randomised, placebo-controlled, observer-blind clinical trial is designed to evaluate the safety, efficacy and immunogenicity of an investigational vaccine (mRNA-1647) for CMV in healthy volunteers.
This Phase 3, randomised, placebo-controlled, observer-blind clinical trial is designed to evaluate the safety, efficacy and immunogenicity of an investigational vaccine (mRNA-1647) for CMV in healthy volunteers.
Paratus Clinical is modern, independent and purpose-built to conduct clinical trials in Australia, with a focus on better recruitment and high quality standards that deliver cost-effective trials.
T: 1300 742 326
